Organogenesis Holdings Inc.
$2.36▼ 3.28%($-0.08)
TickerSpark Score
68/100
▌ Solid
92
Valuation
40
Profitability
95
Growth
84
Health
30
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ORGO research report →
52-Week Range6% of range
Low
$2.04
Current
$2.36
High
$7.08
Company Overvieworganogenesis.com
About the company
Organogenesis Holdings Inc. is a U. S.
- CEO
- Gary S. Gillheeney
- IPO
- 2017
- Employees
- 869
- HQ
- Canton, MA, US
Price Chart
-41.73% · this period
Valuation
- Market Cap
- $303.67M
- P/E
- -16.14
- P/S
- 0.59
- P/B
- 0.79
- EV/EBITDA
- 7.57
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 70.41%
- Op Margin
- 2.14%
- Net Margin
- -0.06%
- ROE
- -0.07%
- ROIC
- -0.16%
Growth & Income
- Revenue
- $563.03M · 16.80%
- Net Income
- $37.03M · 4201.05%
- EPS
- $0.16 · 2353.52%
- Op Income
- $55.87M
- FCF YoY
- -685.73%
Performance & Tape
- 52W High
- $7.08
- 52W Low
- $2.04
- 50D MA
- $2.45
- 200D MA
- $3.64
- Beta
- 1.33
- Avg Volume
- 1.56M
Get TickerSpark's AI analysis on ORGO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Form 4 · Filings
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 10, 25 | Grow Brian | other | 958 |
| Jan 10, 25 | Grow Brian | other | 958 |
| Mar 9, 26 | Leibowitz Arthur S | buy | 5,000 |
| Mar 9, 26 | Driscoll Michael Joseph | buy | 10,000 |
| Mar 1, 26 | Cavorsi Robert | other | 700 |
| Feb 18, 26 | Montecalvo Antonio S. | other | 11,330 |
| Feb 18, 26 | Montecalvo Antonio S. | other | 3,778 |
| Feb 18, 26 | Gillheeney Gary S. | other | 188,856 |
| Feb 18, 26 | Gillheeney Gary S. | other | 91,311 |
| Feb 18, 26 | Grow Brian | other | 48,818 |
Coverage · ORGO
Our ORGO coverage
Recent articles, reports, and earnings notes.
For Active Investors
Want a deeper read on ORGO?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Internal Compare
Similar companies
Peers in the same neighborhood.